Professional Diversity Network, Inc. (IPDN): Nasdaq/NYSE listing notice — IPDN regains compliance with Nasdaq bid price rule; panel monitor lifted

Professional Diversity Network, Inc.

On Jan 20, 2023, Nasdaq imposed a panel monitor requiring compliance with Bid Price Rule until Oct 20, 2023.
On Oct 20, 2023, received end-of-monitor letter confirming compliance with Bid Price Rule.
Nasdaq has determined to continue listing of IPDN's common stock and is closing the matter.
Previously, the company faced potential delisting if compliance was not achieved by the monitor deadline.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Professional Diversity Network, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

October 20, 2023 (the “Panel Monitor”), pursuant to which, if at any time before the end of the monitor period, Nasdaq staff or the Panel determines that the Company has ‎failed to meet the minimum bid price requirement in Listing Rule 5550(a)(2) (the “Bid Price Rule”) (that is, the Company has had a closing bid price under $1.00 ‎for a period of 30 consecutive trading days), or any other requirement for continued listing on Nasdaq, Nasdaq ‎staff will issue a delist determination‎ ‎and a new hearing will be scheduled. On October 20, 2023, the Company received an end of monitor letter from the

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Professional Diversity Network, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-038201

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.